News focus

Oral Insulin: All Mouth, or an Injection of Hope for Type 1 Diabetes?

23-May-2013 - Can oral insulin succeed where other alternative delivery methods have failed? Dan Stanton, from in-Pharmatechnologist.com assesses its chances. 

Updated

Pharma Companies Buzz Over Auto-Injectors Showing Success with High Viscosity Drugs

02-May-2013 - New auto-injector technology that is user-friendly and capable of delivering high viscosity drugs may be the next big thing for pharma and biotech companies pushing further into niche biologics and biosimilars.

Live from Interphex

Regulatory and Financial Burdens Slow IR/MR Approvals, Says Expert

24-Apr-2013 - Efforts to update SUPAC guidance on immediate and modified release dosage forms will end in faster approvals, if regulatory and financial hurdles can be overcome, says expert.

Fujifilm's Cell Banking Facilitates "Larger Slice" of Biologics Pie

23-Apr-2013 - Third-party manufacturers of biologics are seeing increased demand but more short term contracts, according to Fujifilm.

Novaliq Secures Funds to Develop Ocular Delivery Tech

15-Apr-2013 - Novaliq has raised funds to further development of its bioavailability boosting delivery technology and take its candidate dry eye drug into Phase I trials.

BMS Plant Expansion to Push Biologics Development and Manufacturing

15-Apr-2013 - Bristol Myers-Squibb says its $250m (€191m) expansion of its US biologics facility will centralize its processes and become a springboard to launch new products.

GSK Developing Low-Cost Polio Vax Manufacturing Tech with NIBSC

26-Mar-2013 - GSK is working on a low-cost manufacturing platform it will use to produce inactivated polio vaccines (IPV) for developing countries.

New Micron Technologies Owner Plans Investment and Acqusitions

25-Mar-2013 - Micron Technologies’ new private-equity owner says it plans to grow the particle engineering firm through investment and acquisitions.

Novo Nordisk One Step Closer to Long-Acting Oral Insulin

20-Mar-2013 - Novo Nordisk says its long-acting oral insulin could become a lead product following the successful completion of an early-stage trial.

update

Battling Bioavailability? Find Your Solubility Solution at BAC 2013!

18-Mar-2013 - Drug solubility science, technology and solutions will take centre stage at “The Bioavailability Challenge” a free to attend online event in-Pharmatechnologist.com is hosting on Wednesday, March 20. 

Maquet and GSK Boost Novozymes’ Albumin Business

12-Mar-2013 - Novozymes says a recombinant albumin product usually used to stabilize vaccines has been approved in Japan as part of a coating for medical devices.

Mylan Buys Agila Citing Global Injectable Drug Shortages as Driver

04-Mar-2013 - Mylan says its acquisition of Agila puts the generics company in a “leading position” in the injectables market.

Pantarhei Sells Stake in Oral Contraceptive JV

25-Feb-2013 - Pantarhei Bioscience has sold in Estetra, its oral contraceptive development JV, to partner Uteron Pharma and will use the proceeds to fund further development.

GOED: Pharma is important for omega-3 but growing slowly

25-Feb-2013 - Pharmaceutical omega-3 products are important but will grow more slowly than some expect because of the long timeframe for drug approval, says the chief of the Global Organisation for EPA and DHA Omega-3s (GOED).

Unichem Sell Indian Formulation Plant to Mylan

19-Feb-2013 - Mylan Laboratories has purchased a new finished formulations facility in an Indian Special Economic Zone from Unichem Laboratories.

update

Aesica and EmulTech Claim Micro-Encapsulation can Revive Formulation Projects

18-Feb-2013 - Aesica and EmulTech claim a new sterile formulation technology could help drugmakers resurrect abandoned projects and extend the lifespan of marketed medicines.

EpiVax says Novozymes Collaboration has $3bn Potential

13-Feb-2013 - EpiVax says combining its immune 'off switch’ drugs with Novozymes’ half-life boosting Albufuse platform could deliver a $3bn (€2.2bn) section of the autoimmune disease market.

Aduro focus on combinations in purchase of GVAX vaccines

05-Feb-2013 - Aduro says “combinations are the future” after bolstering its immunotherapy portfolio.

Flublok maker open to sharing egg and virus-free manufactuing tech

31-Jan-2013 - Protein Sciences says it will license the novel manufacturing technology behind recently approved influenza vaccine, Flublok, to other producers.

Scinopharm starts developing own drugs with eye on API customers

30-Jan-2013 - Taiwanese API maker Scinopharm has taken a first step towards developing its own drug portfolio in partnership with delivery tech firm Foresee Pharmaceuticals.